<VariationArchive VariationID="30910" VariationName="NM_006662.3(SRCAP):c.7549del (p.Gln2517fs)" VariationType="Deletion" Accession="VCV000030910" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2017-04-21" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39867" VariationID="30910">
      <GeneList>
        <Gene Symbol="SRCAP" FullName="Snf2 related CREBBP activator protein" GeneID="10847" HGNC_ID="HGNC:16974" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30699171" stop="30741409" display_start="30699171" display_stop="30741409" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30710461" stop="30751449" display_start="30710461" display_stop="30751449" Strand="+" />
          </Location>
          <OMIM>611421</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SRCAP">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SRCAP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006662.3(SRCAP):c.7549del (p.Gln2517fs)</Name>
      <CanonicalSPDI>NC_000016.10:30737586:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30737587" stop="30737587" display_start="30737587" display_stop="30737587" variantLength="1" positionVCF="30737586" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30748908" stop="30748908" display_start="30748908" display_stop="30748908" variantLength="1" positionVCF="30748907" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q2517fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.30737589del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.30737589del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.30748910del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.30748910del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032135.1" sequenceAccession="NG_032135" sequenceVersion="1" change="g.43449del">
            <Expression>NG_032135.1:g.43449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006662.3" sequenceAccession="NM_006662" sequenceVersion="3" change="c.7549del" MANESelect="true">
            <Expression>NM_006662.3:c.7549del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006653.2" sequenceAccession="NP_006653" sequenceVersion="2" change="p.Gln2517fs">
            <Expression>NP_006653.2:p.Gln2517fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006662.2" sequenceAccession="NM_006662" sequenceVersion="2" change="c.7549delC">
            <Expression>NM_006662.2:c.7549delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA259943" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611421.0003" DB="OMIM" />
        <XRef Type="rs" ID="199469466" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006662.3(SRCAP):c.7549del (p.Gln2517fs) AND Floating-Harbor syndrome" Accession="RCV000023897" Version="4">
        <ClassifiedConditionList TraitSetID="7891">
          <ClassifiedCondition DB="MedGen" ID="C0729582">Floating-Harbor syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-02-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006662.3(SRCAP):c.7549del (p.Gln2517fs) AND Inborn genetic diseases" Accession="RCV004018671" Version="1">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-21" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22265015</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7891" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5159" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Floating-Harbor syndrome</ElementValue>
                <XRef ID="Floating+Harbor+Syndrome/2877" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007621" DB="MONDO" />
                <XRef ID="312214005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Short stature with delayed bone age, expressive language delay, a triangular face with a prominent nose and deep-set eyes</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelletier-Leisti syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FLHS</ElementValue>
                <XRef Type="MIM" ID="136140" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SRCAP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Floating-Harbor syndrome (FHS) is characterized by typical craniofacial features; low birth weight, normal head circumference, and short stature; bone age delay that normalizes between ages six and 12 years; skeletal anomalies (brachydactyly, clubbing, clinodactyly, short thumbs, prominent joints, clavicular abnormalities); severe receptive and expressive language impairment; hypernasality and high-pitched voice; and intellectual disability that is typically mild to moderate. Difficulties with temperament and behavior that are present in many children tend to improve in adulthood. Other features can include hyperopia and/or strabismus, conductive hearing loss, seizures, gastroesophageal reflux, renal anomalies (e.g., hydronephrosis / renal pelviectasis, cysts, and/or agenesis), and genital anomalies (e.g., hypospadias and/or undescended testes).</Attribute>
                <XRef ID="NBK114458" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6455" />
                <XRef ID="6455" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193612</ID>
                <ID Source="BookShelf">NBK114458</ID>
              </Citation>
              <XRef ID="2044" DB="Orphanet" />
              <XRef ID="C0729582" DB="MedGen" />
              <XRef ID="MONDO:0007621" DB="MONDO" />
              <XRef Type="MIM" ID="136140" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50444" SubmissionDate="2017-04-13" DateLastUpdated="2017-04-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611421.0003_FLOATING-HARBOR SYNDROME" title="SRCAP, 1-BP DEL, 7549C_FLOATING-HARBOR SYNDROME" />
        <ClinVarAccession Accession="SCV000045188" DateUpdated="2017-04-21" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 4.25-year-old boy of German and Mexican descent with Floating-Harbor syndrome (FLHS; 136140), Hood et al. (2012) identified heterozygosity for a de novo 1-bp deletion (7549delC) in exon 34 of the SRCAP gene, causing a frameshift predicted to result in a premature termination codon. The mutation was not present in his unaffected parents and was not represented in the dbSNP (build 131), 1000 Genomes Project, or NHLBI Exome Variant Server databases.</Attribute>
              <Citation>
                <ID Source="PubMed">22265015</ID>
              </Citation>
              <XRef DB="OMIM" ID="136140" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRCAP" />
          </GeneList>
          <Name>SRCAP, 1-BP DEL, 7549C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 7549C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611421.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FLOATING-HARBOR SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9167219" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="a0282744|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004956405" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22265015</ID>
          </Citation>
          <Comment>The c.7549delC (p.Q2517Kfs*5) alteration, located in exon 34 (coding exon 32) of the SRCAP gene, consists of a deletion of one nucleotide at position 7549, causing a translational frameshift with a predicted alternate stop codon after 5 amino acids. This alteration occurs at the 3' terminus of the SRCAP gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 22% of the protein. Premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data)._x000D_ _x000D_ for Floating-Harbor syndrome; however, its clinical significance for SRCAP-related neurodevelopmental disorder is uncertain. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been determined to be the result of a de novo mutation in one individual with features consistent with Floating-Harbor syndrome (Hood, 2012). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SRCAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006662.2:c.7549delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9167219" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50444" TraitType="Disease" MappingType="Name" MappingValue="FLOATING-HARBOR SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0729582" Name="Floating-Harbor syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

